Pharmaceutical Technology on MSN
Takeda and Protagonist seek FDA approval for rusfertide to treat PV
Takeda and Protagonist Therapeutics have jointly submitted a new drug application (NDA) seeking approval from the US Food and ...
Persistent itching can sometimes signal serious illness, including cancer. Oncologist Dr Amit Garg highlights four ...
A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin ...
Polycythemia vera (PV) is a blood cancer that begins in the marrow of your bones, the soft center where new blood cells grow. It causes your marrow to make too many red blood cells so your blood is ...
Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...
While taking testosterone-based HRT, your doctor will monitor your bloodwork for signs of polycythemia. If found, several treatment options are available. Testosterone is responsible for many body ...
Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking ...
Polycythemia vera (PV) is a rare disorder that affects blood cell and platelet production. The early stages of polycythemia vera often cause nonspecific symptoms, but advanced stages can lead to ...
Polycythemia vera is a classic myeloproliferative neoplasm and a chronic type of leukemia, which often leads to overproduction of various blood cells. In this interview, Andrew Kuykendall, MD, ...
Secondary polycythemia is the overproduction of red blood cells. It causes your blood to thicken, which increases the risk of a stroke. It’s a rare condition. The primary function of your red blood ...
Polycythemia vera is a rare condition that affects the bone marrow, which is slow to progress and typically develops in later life. It is a condition characterized by the overproduction of red blood ...
Secondary polycythemia, also known as secondary erythrocytosis or secondary erythrocythemia, is a rare condition in which your body produces an excess amount of red blood cells. This overproduction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results